![]() Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. | ||
Founding Date | Founding Date 2005 | Founding Date 2005 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US |
Employees | Employees 4235% decrease | Employees 3808% increase |
Valuation ($) | Valuation ($) 131.1 m | Valuation ($) 722.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $190k (FY, 2025) | Revenue (est.) $194.1m (FY, 2021) |
Net income | Net income ($74.1m) (FY, 2025) | Net income ($74.8m) (FY, 2021) |

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company